Overview

Amber validation does not end professional practice — it starts the operating conversation. This topic decides what counts as an incident for Model M, how the same evidence is briefed to traders, risk managers and an investment committee, which data and trial-reporting duties bind the researcher, and whether the oral defence supports a bounded trial or a refusal.

By the end of this note you should be able to:

• write a monitoring contract and a short incident note tied to M's thresholds;
• produce three audience-specific briefs without leading on Sharpe alone;
• apply responsible-data duties to M's panel and failed trials without inventing statutes;
• structure an oral defence that a sceptical committee can reject.

1. Contents
2. The big picture